XYLOCAINE DENTAL WITH EPINEPHRINE
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
Approval overview XYLOCAINE DENTAL WITH EPINEPHRINE is listed in Drugs@FDA under application 021381 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient EPINEPHRINE; LIDOCAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.01MG/ML;2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor DENTSPLY PHARM Submission history Latest submission status date: 2018-11-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview XYLOCAINE DENTAL WITH EPINEPHRINE is listed in Drugs@FDA under application 021381 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient EPINEPHRINE; LIDOCAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.01MG/ML;2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor DENTSPLY PHARM Submission history Latest submission status date: 2018-11-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.